Is COCH or RXST more profitable?

RxSight has a net margin of -36.58% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat RxSight's return on equity. Company Net Margins Return on Equity Return on Assets Envoy Medical -9,875.64% N/A -177.92% RxSight -36.58% -17.01% -15.12%

Is COCH or FOCL more profitable?

FocalTherics has a net margin of -41.47% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity. Company Net Margins Return on Equity Return on Assets Envoy Medical -9,875.64% N/A -177.92% FocalTherics -41.47% -137.61% -40.62%

Envoy Medical (COCH) Competitors

$0.69 +0.01 (+1.52%)

Closing price 07/13/2026 04:00 PM Eastern

Extended Trading

$0.72 +0.03 (+3.79%)

As of 09:16 AM Eastern

Compare

COCH vs. VANI, RXST, SMTI, KRMD, and FOCL

Should you buy Envoy Medical stock or one of its competitors? MarketBeat compares Envoy Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Envoy Medical include Vivani Medical (VANI), RxSight (RXST), Sanara MedTech (SMTI), KORU Medical Systems (KRMD), and FocalTherics (FOCL). These companies are all part of the "medical equipment" industry.

How does Envoy Medical compare to Vivani Medical?

Vivani Medical (NASDAQ:VANI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation, dividends and media sentiment.

Vivani Medical has a beta of 2.33, suggesting that its stock price is 133% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market.

Vivani Medical presently has a consensus price target of $3.75, indicating a potential upside of 164.08%. Envoy Medical has a consensus price target of $2.50, indicating a potential upside of 260.39%. Given Envoy Medical's higher probable upside, analysts plainly believe Envoy Medical is more favorable than Vivani Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Vivani Medical	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.25
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Envoy Medical has higher revenue and earnings than Vivani Medical. Vivani Medical is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Vivani Medical	N/A	N/A	-$26.61M	-$0.40	N/A
Envoy Medical	$240K	222.22	-$23.76M	-$1.01	N/A

In the previous week, Vivani Medical had 13 more articles in the media than Envoy Medical. MarketBeat recorded 14 mentions for Vivani Medical and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat Vivani Medical's score of 0.64 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Vivani Medical	Positive
Envoy Medical	Very Positive

Vivani Medical has a net margin of 0.00% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Vivani Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Vivani Medical	N/A	-264.04%	-79.85%
Envoy Medical	-9,875.64%	N/A	-177.92%

6.8% of Vivani Medical shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 53.3% of Vivani Medical shares are owned by company insiders. Comparatively, 7.1% of Envoy Medical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

Vivani Medical beats Envoy Medical on 8 of the 15 factors compared between the two stocks.

How does Envoy Medical compare to RxSight?

Envoy Medical (NASDAQ:COCH) and RxSight (NASDAQ:RXST) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, analyst recommendations, risk, valuation and media sentiment.

RxSight has a net margin of -36.58% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat RxSight's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
RxSight	-36.58%	-17.01%	-15.12%

Envoy Medical has a beta of 1.88, suggesting that its stock price is 88% more volatile than the broader market. Comparatively, RxSight has a beta of 1.15, suggesting that its stock price is 15% more volatile than the broader market.

Envoy Medical presently has a consensus price target of $2.50, indicating a potential upside of 260.39%. RxSight has a consensus price target of $8.89, indicating a potential upside of 75.67%. Given Envoy Medical's stronger consensus rating and higher probable upside, research analysts plainly believe Envoy Medical is more favorable than RxSight.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
RxSight	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

Envoy Medical has higher earnings, but lower revenue than RxSight. RxSight is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	222.22	-$23.76M	-$1.01	N/A
RxSight	$134.48M	1.56	-$38.94M	-$1.13	N/A

In the previous week, RxSight had 12 more articles in the media than Envoy Medical. MarketBeat recorded 13 mentions for RxSight and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat RxSight's score of 0.30 indicating that Envoy Medical is being referred to more favorably in the media.

Company	Overall Sentiment
Envoy Medical	Very Positive
RxSight	Neutral

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 78.8% of RxSight shares are held by institutional investors. 7.1% of Envoy Medical shares are held by insiders. Comparatively, 10.1% of RxSight shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Envoy Medical beats RxSight on 9 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to Sanara MedTech?

Sanara MedTech (NASDAQ:SMTI) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, media sentiment, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.

Envoy Medical has lower revenue, but higher earnings than Sanara MedTech. Sanara MedTech is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sanara MedTech	$103.12M	2.21	-$37.56M	-$3.77	N/A
Envoy Medical	$240K	222.22	-$23.76M	-$1.01	N/A

Sanara MedTech has a net margin of -31.23% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat Sanara MedTech's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sanara MedTech	-31.23%	-3.19%	-0.56%
Envoy Medical	-9,875.64%	N/A	-177.92%

8.1% of Sanara MedTech shares are owned by institutional investors. Comparatively, 8.6% of Envoy Medical shares are owned by institutional investors. 42.0% of Sanara MedTech shares are owned by insiders. Comparatively, 7.1% of Envoy Medical shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Sanara MedTech currently has a consensus target price of $34.00, suggesting a potential upside of 36.44%. Envoy Medical has a consensus target price of $2.50, suggesting a potential upside of 260.39%. Given Envoy Medical's higher possible upside, analysts clearly believe Envoy Medical is more favorable than Sanara MedTech.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sanara MedTech	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Sanara MedTech had 1 more articles in the media than Envoy Medical. MarketBeat recorded 2 mentions for Sanara MedTech and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat Sanara MedTech's score of 1.45 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
Sanara MedTech	Positive
Envoy Medical	Very Positive

Sanara MedTech has a beta of 1.18, indicating that its stock price is 18% more volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, indicating that its stock price is 88% more volatile than the broader market.

Summary

Envoy Medical beats Sanara MedTech on 9 of the 17 factors compared between the two stocks.

How does Envoy Medical compare to KORU Medical Systems?

KORU Medical Systems (NASDAQ:KRMD) and Envoy Medical (NASDAQ:COCH) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, risk, institutional ownership, media sentiment, earnings, analyst recommendations, valuation and profitability.

KORU Medical Systems currently has a consensus price target of $7.25, indicating a potential upside of 71.39%. Envoy Medical has a consensus price target of $2.50, indicating a potential upside of 260.39%. Given Envoy Medical's higher probable upside, analysts plainly believe Envoy Medical is more favorable than KORU Medical Systems.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
KORU Medical Systems	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

KORU Medical Systems has a net margin of -5.27% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat KORU Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
KORU Medical Systems	-5.27%	-13.61%	-8.33%
Envoy Medical	-9,875.64%	N/A	-177.92%

58.6% of KORU Medical Systems shares are held by institutional investors. Comparatively, 8.6% of Envoy Medical shares are held by institutional investors. 18.5% of KORU Medical Systems shares are held by insiders. Comparatively, 7.1% of Envoy Medical shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

KORU Medical Systems has higher revenue and earnings than Envoy Medical. KORU Medical Systems is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
KORU Medical Systems	$41.13M	4.72	-$2.64M	-$0.05	N/A
Envoy Medical	$240K	222.22	-$23.76M	-$1.01	N/A

KORU Medical Systems has a beta of 0.41, meaning that its share price is 59% less volatile than the broader market. Comparatively, Envoy Medical has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market.

In the previous week, KORU Medical Systems had 2 more articles in the media than Envoy Medical. MarketBeat recorded 3 mentions for KORU Medical Systems and 1 mentions for Envoy Medical. Envoy Medical's average media sentiment score of 1.87 beat KORU Medical Systems' score of 0.62 indicating that Envoy Medical is being referred to more favorably in the news media.

Company	Overall Sentiment
KORU Medical Systems	Positive
Envoy Medical	Very Positive

Summary

KORU Medical Systems beats Envoy Medical on 10 of the 16 factors compared between the two stocks.

How does Envoy Medical compare to FocalTherics?

Envoy Medical (NASDAQ:COCH) and FocalTherics (NASDAQ:FOCL) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, media sentiment, dividends, institutional ownership, valuation and profitability.

Envoy Medical has higher earnings, but lower revenue than FocalTherics. FocalTherics is trading at a lower price-to-earnings ratio than Envoy Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Envoy Medical	$240K	222.22	-$23.76M	-$1.01	N/A
FocalTherics	$70.53M	2.89	-$29.25M	-$0.81	N/A

8.6% of Envoy Medical shares are held by institutional investors. Comparatively, 62.7% of FocalTherics shares are held by institutional investors. 7.1% of Envoy Medical shares are held by company insiders. Comparatively, 10.1% of FocalTherics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Envoy Medical has a beta of 1.88, meaning that its share price is 88% more volatile than the broader market. Comparatively, FocalTherics has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market.

Envoy Medical presently has a consensus price target of $2.50, indicating a potential upside of 260.39%. FocalTherics has a consensus price target of $6.00, indicating a potential upside of 10.50%. Given Envoy Medical's higher probable upside, equities research analysts clearly believe Envoy Medical is more favorable than FocalTherics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Envoy Medical	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
FocalTherics	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

FocalTherics has a net margin of -41.47% compared to Envoy Medical's net margin of -9,875.64%. Envoy Medical's return on equity of 0.00% beat FocalTherics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Envoy Medical	-9,875.64%	N/A	-177.92%
FocalTherics	-41.47%	-137.61%	-40.62%

In the previous week, Envoy Medical and Envoy Medical both had 1 articles in the media. FocalTherics' average media sentiment score of 1.89 beat Envoy Medical's score of 1.87 indicating that FocalTherics is being referred to more favorably in the news media.

Company	Overall Sentiment
Envoy Medical	Very Positive
FocalTherics	Very Positive

Summary

FocalTherics beats Envoy Medical on 7 of the 13 factors compared between the two stocks.

Get Envoy Medical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COCH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COCH vs. The Competition

Export

Metric	Envoy Medical	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$52.53M	$7.63B	$7.05B	$12.61B
Dividend Yield	N/A	1.32%	2.68%	8.00%
P/E Ratio	-0.69	50.28	27.10	24.26
Price / Sales	222.22	76.45	588.85	117.88
Price / Cash	N/A	26.85	29.22	49.36
Price / Book	-1.65	7.32	10.85	6.29
Net Income	-$23.76M	$162.30M	$3.58B	$330.66M
7 Day Performance	-8.72%	-0.99%	-2.12%	-1.35%
1 Month Performance	10.48%	0.19%	3.27%	-0.64%
1 Year Performance	-55.53%	4.08%	26.33%	19.08%

Envoy Medical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COCH Envoy Medical	2.7676 of 5 stars	$0.69 +1.5%	$2.50 +260.4%	-55.2%	$52.53M	$240K	N/A	34	Positive News Gap Up
VANI Vivani Medical	3.4509 of 5 stars	$1.55 +14.4%	$3.75 +142.7%	+1.4%	$136.69M	N/A	N/A	20	News Coverage High Trading Volume
RXST RxSight	2.8648 of 5 stars	$5.50 -2.1%	$8.89 +61.5%	-36.8%	$228.20M	$134.48M	N/A	220	Analyst Upgrade
SMTI Sanara MedTech	2.4429 of 5 stars	$24.28 -2.1%	$34.00 +40.1%	-14.2%	$222.15M	$103.12M	N/A	60	News Coverage Positive News
KRMD KORU Medical Systems	4.273 of 5 stars	$4.47 -2.6%	$7.25 +62.2%	+21.6%	$205.31M	$41.13M	N/A	80

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COCH) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Envoy Medical (COCH) Competitors

COCH vs. VANI, RXST, SMTI, KRMD, and FOCL

How does Envoy Medical compare to Vivani Medical?

Summary

How does Envoy Medical compare to RxSight?

Summary

How does Envoy Medical compare to Sanara MedTech?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Summary

How does Envoy Medical compare to FocalTherics?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Envoy Medical (COCH) Competitors

COCH vs. VANI, RXST, SMTI, KRMD, and FOCL

How does Envoy Medical compare to Vivani Medical?

Which has more volatility & risk, VANI or COCH?

Do analysts rate VANI or COCH?

Which has better earnings and valuation, VANI or COCH?

Does the media refer more to VANI or COCH?

Is VANI or COCH more profitable?

Do insiders & institutionals believe in VANI or COCH?

Summary

How does Envoy Medical compare to RxSight?

Is COCH or RXST more profitable?

Which has more risk and volatility, COCH or RXST?

Do analysts rate COCH or RXST?

Which has better earnings and valuation, COCH or RXST?

Does the media prefer COCH or RXST?

Do insiders and institutionals believe in COCH or RXST?

Summary

How does Envoy Medical compare to Sanara MedTech?

Which has higher valuation and earnings, SMTI or COCH?

Is SMTI or COCH more profitable?

Do insiders and institutionals have more ownership in SMTI or COCH?

Do analysts recommend SMTI or COCH?

Does the media refer more to SMTI or COCH?

Which has more risk and volatility, SMTI or COCH?

Summary

How does Envoy Medical compare to KORU Medical Systems?

Do analysts recommend KRMD or COCH?

Is KRMD or COCH more profitable?

Do insiders and institutionals believe in KRMD or COCH?

Which has preferable earnings & valuation, KRMD or COCH?

Which has more volatility & risk, KRMD or COCH?

Does the media favor KRMD or COCH?

Summary

How does Envoy Medical compare to FocalTherics?

Which has higher valuation and earnings, COCH or FOCL?

Do insiders and institutionals hold more shares of COCH or FOCL?

Which has more risk and volatility, COCH or FOCL?

Do analysts rate COCH or FOCL?

Is COCH or FOCL more profitable?

Does the media refer more to COCH or FOCL?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COCH vs. The Competition

Envoy Medical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools